Published groundbreaking research from IMBCR has provided the gateway to transformative clinical trials resulting in superior outcomes for patients. This has resulted in an extended life expectancy for myeloma patients – on the average of a decade today and continues to improve!
Read the stories of patients who have been directly impacted by IMBCR research efforts and are LIVING BETTER and LIVING LONGER.
John Cook
During an executive physical in 2016, I had an abnormal protein spike. After meeting with their hematologist, I searched, literally the world for the best of the best. I came across IMBCR, a research group dedicated to advancing the treatment of multiple myeloma…
I then met with Dr Berenson, a clinician who applies this knowledge to his practice. After looking at the total package, I hands down went with Dr Berenson. His knowledge and enthusiasm are incredible. His people are top notch; the caring and professionalism they have are greatly appreciated.
The first time I met with Dr Berenson I was scared, big time. He helped me relax. Especially knowing they are on my team has a very calming effect.
Today, I don’t really have any pain and the drugs are not messing with my mind. If one drug does not work for you, he will come up with another one. My life has not changed as far as activities, still golf, ski, walk etc.
Dr. Berenson is truly an amazing person. This is what he does. Every time I meet with him, I walk out of there thinking that same thing. I am extremely thankful to Dr Berenson, his team, & the research conducted at IMBCR. I have been a financial supporter to IMBCR since my first visit to their office.
It came out of no-where, I had no symptoms. My hematologist called to see me and informed us that my MGUS had progressed to full blown multiple myeloma – and my life expectancy would be no more than 1-2 years!
Sidney Teichman
Richard Gardiner, MD
I am a physician and have been a competitive and solo athlete all my life. In 2019, I ran over three miles per day. The year 2020 was quite different! Starting in January, I experienced what was initially subtle but rapidly progressive bone pain, tingling nerves, profound weakness, and easy fatiguability. My primary care physician ordered exams and then referred me to a local oncologist, who, in February, told me I had multiple myeloma. He said he would welcome me into his care and later told me I had been “on death’s door.
To quote the actress Betty Davis, “Getting old is not for sissies”, and I have not been spared to have issues with my health. My diagnosis with multiple myeloma was initially discovered seven years ago when I had a CAT scan looking for something else.
I was recommended by a world-renowned oncologist to contact Dr. James Berenson to deal with it and I am most grateful for this. For the first five years, the multiple myeloma was smoldering not full blown. The condition worsened, and I was put on a chemo regimen.
Dr. Berenson believes in treatment that lets a patient lead the best life possible. I have been able to continue my ability to travel anywhere my heart or my wife Suzanne desires (though not for the last nine months – due to Covid) and to exercise, play tennis, and do yoga. I have personally been a big supporter of the research conducted at IMBCR. As a result of this research, IMBCR and Dr. Berenson identified a marker that shows if a regimen of drug used in treatment is helping along with a combination of JAK inhibitors with immunomodulatory agents for cancer applications. I have seen these findings benefit Dr. Berenson’s patients directly.
Rob D.
—Read the stories of patients who have been directly impacted by IMBCR research efforts and are “MAKING the impossible POSSIBLE!”
Hope, Quality of Life, Love, Living, Passion, Curiosity
The IMBCR Patient Impact
YOU have WHAT?
YOU have WHAT? (the companion book to I Have WHAT?) is now available for purchase. It is a helpful resource for caregivers as well as patients and their families. Caregivers share candid stories about their experiences with Multiple Myeloma, Waldenstrom’s Macroglobulinemia, Amyloidosis, and MGUS (Monoclonal Gammopathy of Undetermined Significance). The book also contains practical advice from healthcare professionals who are experts at caring for these patients.
All proceeds will support IMBCR which is a 501(c)3 organization and tax deductible to the extent permitted by law.
Available for a donation: $45 (price includes cost of book – $40 plus shipping & handling – $5)
I have WHAT?
I have WHAT? (the companion book to YOU Have WHAT?) is a helpful resource for patients as well as their families and caregivers. Patients share candid stories about their experiences with Multiple Myeloma, Waldenstrom’s Macroglobulinemia, Amyloidosis, and MGUS (Monoclonal Gammopathy of Undetermined Significance). The book also contains practical advice from healthcare professionals who are experts at caring for these patients.
The third edition features the latest information regarding these diseases and is now available for purchase.
All proceeds will support IMBCR which is a 501(c)3 organization and tax deductible to the extent permitted by law.
Available for a donation: $45 (price includes cost of book – $40 plus shipping & handling – $5)